Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
02/2007
02/21/2007EP1753763A2 Indazole and indolone derivatives and their use as pharmaceuticals
02/21/2007EP1753758A1 Mercaptoimidazoles as ccr2 receptor antagonists
02/21/2007EP1753757A1 Substituted 2,5-diaminomethyl-1h-pyrroles
02/21/2007EP1753756A1 3-¬4-(6-{4,5-dihydroisoxazol-3-yl}pyridin-3-yl)-3-phenyl|-5-(1h-1,2,3-triazol-1-ylmethyl)-1,3-oxazolidin-2-ones as antibacterial agents
02/21/2007EP1753755A1 3- {4- (pyridin-3-yl) phenyl} -5- (1h-1, 2, 3-triazol-1-ylmethyl) -1, 3-oxazolidin-2-ones as antibacterial agents
02/21/2007EP1753754A1 3- '4- {6-substituted alkanoyl) pyridin-3-yl} -3-phenyl! -5- (1h-1, 2, 3-triazol-1-ylmethyl) -1, 3-oxazolidin-2-ones as antibacterial agents
02/21/2007EP1753753A1 3-(4-(2-dihydroisoxazol-3-ylpyrdin-5-yl)phenyl)-5-triazol-1-ylmethyloxazolidin-2-one derivatives as mao inhibitors for the treatment of bacterial infections
02/21/2007EP1753752A1 Highly selective novel amidation method
02/21/2007EP1753751A1 Process for the preparation of aryl substituted oxazolidinones as intermediates for antibacterial agents
02/21/2007EP1753748A1 Proline derivatives and their use as dipeptidyl peptidase iv inhibitors
02/21/2007EP1753745A2 Pyrazinylmethyl lactam derivatives
02/21/2007EP1753743A1 Pyridazinone derivatives, methods for producing them and their use as pharmaceuticals
02/21/2007EP1753736A2 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
02/21/2007EP1753727A1 Novel cis-imidazolines
02/21/2007EP1753721A1 Aroyl-o-piperidine derivatives for the treatment of diabetes-related problems
02/21/2007EP1753423A2 Benzoureas having anti-diabetic activity
02/21/2007EP1575900A4 N-methyl amino acids
02/21/2007EP1511727B1 Aromatic sulfones and their medical use
02/21/2007EP1355905B1 Pyrazole compounds useful as protein kinase inhibitors
02/21/2007EP1000025B1 Substituted naphthopyrans
02/21/2007CN1918154A Poly-heterocyclic compounds and their use as metabotropic glutamate receptor antagonists
02/21/2007CN1918153A Oxazole derivatives, preparation and therapeutic use thereof
02/21/2007CN1918147A 1,2,3,4-tetrahydroisoquinoline derivatives, preparations thereof and uses thereof
02/21/2007CN1917921A Calcitonin gene related peptide receptor antagonists
02/21/2007CN1917881A Novel phenylalanine derivatives
02/21/2007CN1917880A Pyrimidines with tie2 (tek) activity
02/21/2007CN1917879A Pyrimidines with tie2 (tek) activity
02/21/2007CN1915991A Synthesis of indole thiazole compounds as ligands for the ah receptor
02/21/2007CN1915981A 2-oxy-benzoxazinone derivatives for the treatment of obesity
02/21/2007CN1915231A Use of nonsteroidal in preparing drug of antiinflammatory agents
02/20/2007US7179922 Chemical compounds
02/20/2007US7179918 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
02/20/2007US7179910 3-(4-amidopyrrol-2-ylmethlidene)-2-indolinone derivatives as protein kinase inhibitors
02/20/2007US7179835 2-(3-sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors
02/20/2007US7179828 Antiproliferative, anticarcinogenic and antifungal agents; food and cosmetic preservatives
02/20/2007US7179826 Antiproliferative agnets; antitumor agents; anticancer agents; cardiovascular disorders; central nervous system disorders; autoimmune diseases; antiinflammatory agents
02/20/2007US7179823 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity
02/20/2007US7179822 Hetero biaryl derivatives as matrix metalloproteinase inhibitors
02/20/2007US7179819 Benzyl -urea, -thiourea, or -guanidine derivatives that inhibit the binding of ligands to alpha 4 beta 1 integrin (VLA-4); for therapy and prophylaxis of pathologies associated with VLA-4 mediated cell adhesion, such as inflammatory and autoimmune diseases, and tumor metastasis
02/20/2007US7179815 For example, 3-[2(R)-{hydroxycarbonylpropyl-amino}-2-phenylethyl]-5-(2-fluoro-3-methoxyphenyl)-1-[2-fluoro-6-(trifluoromethyl)benzyl]-6-methyl-pyrimidine-2,4(1H,3H)-dione; use in treating prostate cancer, benign prostatic hypertrophy, breast cancer and endometriosis
02/20/2007US7179812 Such as 3-(4-[1,2,3]Triazol-1-yl-but-1-ynyl)-6-{2-[2-(4-trifluoromethyl-phenyl)-vinyl]-oxazol-4-ylmethoxy}-pyridazine; for treatment of cancer, tumor growth; antiproliferative agents
02/20/2007US7179808 Such as 3-[[4-(4-chlorophenyl)-2-thiazolyl]methoxy]-N-propyl-benzenemethanamine; nicotinamide adenine dinucleotide oxidase hydride donor inhibitors
02/20/2007US7179807 5-substituted-2-arylpyrazines
02/20/2007US7179806 Δ1-pyrrolines used as pesticides
02/20/2007US7179804 Tachykinin receptor antagonists
02/20/2007US7179794 Antibiotics; bactericides
02/20/2007CA2344574C Thyroid receptor ligands
02/20/2007CA2186784C The use of carboxylic acid derivatives as drugs
02/20/2007CA2180156C Self-assembled taxo-diperpenoid nanostructures
02/20/2007CA2119745C Nonpeptidyl integrin inhibitors having specificity for gpiibiiia receptor
02/20/2007CA2085192C Fungicidal derivatives of 2-imidazoline-5-ones and 2-imidazoline-5-thiones
02/15/2007WO2007018941A2 Pyrimidyl-thiophene derivatives
02/15/2007WO2007018168A1 Acylguanidine derivative or salt thereof
02/15/2007WO2007018110A1 Thermosetting compound, composition containing the same, and molding
02/15/2007WO2007017740A1 Salts and polymorphs of a vergf-r inhibitor
02/15/2007WO2007017669A1 Azole and thiazole derivatives and their use
02/15/2007WO2007017222A1 Pyrazole derivatives, their manufacture and their use as pharmaceutical agents
02/15/2007WO2007017096A1 Pyrazine derivatives useful as adenosine receptor antagonists
02/15/2007WO2007016979A2 NOVEL HETEROCYCLIC NF-κB INHIBITORS
02/15/2007WO2006136829A3 Pyrazole derivatives and their use as pka and pkb modulators
02/15/2007WO2006135649A3 Aminoquinoline and aminoquinazoline kinase modulators
02/15/2007WO2006133242A3 Azinone and diazinone v3 inhibitors for depression and stress disorders
02/15/2007WO2006111285A3 Imino-oxazolidines and use thereof as anticoagulants
02/15/2007WO2006103120A3 New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-alzheimer agents
02/15/2007WO2005123703A8 Alkynyl derivatives as modulators of metabotropic glutamate receptors
02/15/2007US20070037974 Inhibitors of P2X3
02/15/2007US20070037888 4-(Pyrazol-3-ylamino) pyrimidine derivatives for use in the treatment of cancer
02/15/2007US20070037868 Macrocyclic diaminopropanes as beta-secretase inhibitors
02/15/2007US20070037865 Sirtuin modulating compounds
02/15/2007US20070037853 N-(3-aminopropyl)-N-{1-[1-benzyl-4-(3-chlorophenyl)-1H-imidazol-2-yl]-2-methylpropyl}morpholine-4-carboxamide and derivatives; kinesin spindle protein (KSP) inhibitors; anticarcinogenic agents; antimiotic; gene expression inhibition
02/15/2007US20070037836 Melanin concentrating hormone; obesity and related disorders, anxiety, or depression; trans-4-Bromo-N-{4-[(4-dimethylamino-quinazolin-2-ylamino)-methyl]-cyclohexylmethyl}-2-trifluoromethoxy-benzenesulfonamide
02/15/2007US20070037820 Substituted piperazines as metabotropic glutamate receptor antagonists
02/15/2007US20070037819 Treating chronic neuropathic or inflammatory pain; [(1-methyl-1H-pyrrol-2-yl)methyl][[1-[(4-pyrazin-2-ylpiperazin-1-yl)acetyl]-4-[3-trifluoromethyl)phenyl]piperid-4-yl]methyl]amine
02/15/2007US20070037808 Anti-inflammatory medicaments
02/15/2007US20070037807 Pyridine compounds as inhibitors of dipeptidyl peptidase IV
02/15/2007US20070037806 Pyrrolidine derivatives as oxytocin antagonists
02/15/2007US20070037803 Benzimidazole derivatives
02/15/2007US20070037802 Substituted-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands
02/15/2007US20070037801 Novel indoles are cannabinoid receptor ligands
02/15/2007US20070037796 e.g. 7-Phenyl-isoquinoline-5-sulfonic acid {2-[3 -(4-nitrophenyl)-propylamino]-ethyl}-amide, dihydrochloride salt; antiviral, antineoplastic, anticarcinogenic agents; neoplasms
02/15/2007US20070037795 2-methyl-1-[2-(4-nitrophenoxy)-ethyl]-1,2,3,4-tetrahydroisoquinolin-6-yl dimethylcarbamate; Acetylcholinesterase inhibitors; selective serotonin reuptake inhibitory; Alzheimer's disease, depression, Huntington's chorea, Pick's disease, tardive dyskinesia, compulsive disorders or panic disorders
02/15/2007US20070037794 Heteroaryl sulfonamides and CCR2
02/15/2007US20070037793 2-methyl-1-[2-(4-nitrophenoxy)-ethyl]-1,2,3,4-tetrahydroisoquinolin-6-yl dimethylcarbamate; Acetylcholinesterase inhibitors; selective serotonin reuptake inhibitory; Alzheimer's disease, depression, Huntington's chorea, Pick's disease, tardive dyskinesia, compulsive disorders or panic disorders
02/15/2007US20070037788 5-(3,8-Difluoro-6H-dibenzo[b,e]oxepin-11-ylidenemethyl)-1-(1-ethyl-pyrrolidin-3-yl) -1,3-dihydro-benzoimidazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia
02/15/2007US20070037752 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases
02/15/2007US20070037012 having an anthracene compound substituted with at least one thiophenyl ring; OLED organic light emitters; as displays with low power consumption, faster response time, higher brightness level, unlimited viewing angle
02/15/2007US20070036854 Therapeutic applications of pro-apoptotic benzodiazepines
02/15/2007CA2618888A1 Acyltryptophanols for fertility control
02/15/2007CA2617964A1 Azole and thiazole derivatives and their uses
02/15/2007CA2617473A1 Acylguanidine derivative or salt thereof
02/15/2007CA2617225A1 Novel heterocyclic nf-kb inhibitors
02/15/2007CA2616428A1 Pyrazine derivatives useful as adenosine receptor antagonists
02/15/2007CA2616075A1 Pyrazole derivatives, their manufacture and their use as pharmaceutical agents
02/15/2007CA2615760A1 Salts and polymorphs of n,2-dimethyl-6-[7-(2-morpholinoethoxy)quinolin-4-yloxy]benzofuran-3-carboxamide
02/14/2007EP1752455A2 Chemokine receptor binding heterocyclic compounds
02/14/2007EP1751149A1 Bicyclic-substituted amines having cyclic-substituted monocyclic substituents
02/14/2007EP1751143A1 Pyrimidine derivatives for the treatment of abnormal cell growth
02/14/2007EP1751141A1 Novel pyridazinone derivatives as inhibitors of cdk2
02/14/2007EP1751136A2 Nitrogenated heterocyclic derivatives as protein kinase modulators and use for the treatment of angiogenesis and cancer
02/14/2007EP1751133A2 Compositions useful as inhibitors of rock and other protein kinases